VOD Q4 2025 Earnings EPS Surges 408 Above Estimates Stock Edges Higher GPMT Q1 2026 Earnings Surprise EPS Beat Signals Operational Resilience LPX Q1 2026 Earnings Stellar EPS Surprise of 218 Highlights Operational Strength Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts EFSCP Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher HNVR Q1 2026 Earnings Slight EPS Miss Amid Challenging Operating Environment